• Daiichi Sankyo Listed on DJSI World Index as the first Japanese company from the pharmaceutical sector
  • Partnership to launch “Access Accelerated”
  • Inspiring a New Generation of Scientists
  • DS Library
  • DS Library
  • e-healthy recipe

Featured Stories

Who We Are

Who We Are

Daiichi Sankyo is a global pharmaceutical company with its corporate origin in Japan.
read more ...

Investor Relations

Investor Relations

The FY2017 second quarter financial results are now available.
read more ...

Featured News

Date
Description  
2017.11.15
Press Release
New LIXIANA® sub-analysis from the ENGAGE AF-TIMI 48 trial presented at the American Heart Association Annual Scientific Sessions 2017 PDF
2017.10.31
Press Release
Daiichi Sankyo Announces ENLIVEN Phase 3 Study of Pexidartinib Met Primary Endpoint in Tenosynovial Giant Cell Tumor PDF
2017.10.31
Press Release
Daiichi Sankyo Announces Determination of Matters Relating to Acquisition of Own Shares PDF
2017.10.30
Press Release
Daiichi Sankyo and Glycotope Announce Option Agreement for Antibody Drug Conjugate Strategic Collaboration and Licensing PDF
2017.10.17
Press Release
Daiichi Sankyo Announces Support by the Japan Agency for Medical Research and Development’s CiCLE Program for Its Collaborative Research with Saitama Medical University on Fibrodysplasia Ossificans Progressiva, and Commencement of an Industry-Government-Academia Research & Development Collaboration for Development of Therapies Using the Research PDF
2017.10.16
Press Release
Commencement of Collaborative Research on Measurement of Exosomes in Blood from Cancer Patients PDF
2017.10.12
Press Release
Daiichi Sankyo Announces Support from the Japan Agency for Medical Research and Development’s CiCLE Program for Its Genetic Vaccine Platform, and Commencement of an Industry- Government-Academia Research & Development Collaboration for Development Vaccines Using the Platform PDF
2017.10.11
Press Release
Astellas, Mitsubishi Tanabe Pharma, and Daiichi Sankyo Conduct “JOINUS,” a New Drug Discovery Program Using Drug-Repositioning Compound Library PDF
2017.10.06
Press Release
Daiichi Sankyo to Install Call Center Support System in Japan Utilizing Artificial Intelligence PDF
2017.09.29
Press Release
Daiichi Sankyo Underwrites All Shares Issued by Kitasato Daiichi Sankyo Vaccine PDF